Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study | Journal of Pharmaceutical Health Care and Sciences | Full Text

Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study | Journal of Pharmaceutical Health Care and Sciences | Full Text

Journal of Pharmaceutical Health Care and Sciences

Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study

Cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) regimen includes a high dose of prednisolone (100 mg/body), which exhibits an anticancer and antiemetic effect. However, its optimal use for ...

Authors:Yoshinori Wakasugi, Satoshi Noda, Yoshihiro Ikuno, Miya Horie, Katsuyuki Kito, Hitoshi Minamiguchi and Tomohiro Terada

Citation:Journal of Pharmaceutical Health Care and Sciences 2019 5:24

Content type:Research article

Published on: 21 November 2019

• ViewFull Text
 
• ViewPDF